Pay in 4 interest-free payments of $5.22 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Globally launched clinical trials like the European study DISCOVERY showed that antiviral drugs (remdesivir, lopinavir and ritonavir in combination, ritonavir given with or without interferon beta and hydroxychloroquine) are unable to efficiently attack COVID-19 progression (Ader et al., 2022)
Rodent studies have reported upregulation of VEGF receptor 2 (VEGFR2) and associated endothelial cell migration markers following BPC-157 administration
nanoparticle formulations co-delivering immumodulators + checkpoint inhibitors
NDA filed with the FDA on December 18, 2025 by Novo Nordisk
US$ 27.34
US$ 20.24
US$ 27.51
US$ 28.05
